John G Paty Jr. is a Hixson, Tennessee based male rheumatologist who is specialized in Rheumatology. Active license number of John G Paty Jr. for Rheumatology is 5955 in Tennessee. John G Paty Jr. treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
John G Paty Jr. speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1831133610
NPI Enumeration Date:
15 Jun, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for John G Paty Jr. are as mentioned below.
License Number
Specialization
State
Status
5955
Rheumatologist
Tennessee
Primary
Other Medical Identifiers:
Other legacy medical identifiers associated with John G Paty Jr. such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
62032
Other
Tennessee
BLUE CROSS
2008308
Other
Tennessee
BLUE CROSS GROUP ID
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1035 Executive Drive, Hixson, Tennessee
Zip:
37343-7908
Phone Number:
423-826-0800
Fax Number:
423-826-0810
Patients can reach John G Paty Jr. at 1035 Executive Drive, Hixson, Tennessee or can call to book an appointment on 423-826-0800. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.